ARV-393, A PROTAC BCL6 DEGRADER, IS EFFICACIOUS IN PRECLINICAL MODELS OF DIFFUSE LARGE B CELL LYMPHOMA (DLBCL), NODAL T-FOLLICULAR HELPER CELL LYMPHOMA (NTFHL), AND TRANSFORMED FOLLICULAR LYMPHOMA (TFL)
EHA Library, Anna Van Acker, 4159412
CD4+ T CELL RECRUITMENT AND DIFFERENTIATION INTO A CYTOTOXIC PHENOTYPE IS ASSOCIATED WITH THE TREATMENT OF DLBCL PATIENTS WITH GLOFITAMAB TOGETHER WITH R-CHOP OR POLA-R-CHP
EHA Library, Thiago M Steiner, 4159413
PROGNOSTIC VALUE OF CIRCULATING TUMOR DNA (CTDNA) DETECTION BY PHASED-SEQ AFTER AXICABTAGENE CILOLEUCEL (AXI-CEL) THERAPY IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (LBCL)
EHA Library, Brodie Miles, 4159414
COMBINATION WITH MOSUNETUZUMAB AND LENALIDOMIDE ENHANCES THE NUMBER OF CD8+ T CELLS WITH HIGH T CELL-DEPENDENT CELLULAR CYTOTOXIC ACTIVITY AGAINST FOLLICULAR LYMPHOMA CELLS
EHA Library, Hayato Mizuta, 4159415
FGF SIGNALING BLOCKADE HAMPERS THE GROWTH OF C-MYC-DRIVEN AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA
EHA Library, Jessica Faletti, 4159416
MAGNOLIN INHIBITS THE PROGRESSION OF DIFFUSE LARGE B-CELL LYMPHOMA BY ACTIVATING PPARG/PINK1-PARKIN AXIS AND PROMOTING MITOPHAGY
EHA Library, Shunfeng Hu, 4159417
CD19 EXPRESSION IS RETAINED IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA AFTER RECEIVING TAFASITAMAB, LENALIDOMIDE AND RITUXIMAB IN THE INMIND STUDY
EHA Library, Diana Alvarez Arias, 4159418
LONG-TERM SURVIVAL FOR LYMPHOID NEOPLASMS AND NATIONAL HEALTH EXPENDITURE (EUROCARE-6): A RETROSPECTIVE, POPULATION-BASED STUDY
EHA Library, Claudia Vener, 4159419
CHIDAMIDE ENHANCES CD7 CAR T-CELL EFFICACY IN T-CELL LYMPHOMA THROUGH EPIGENETIC CD7 UPREGULATION AND MITOCHONDRIAL APOPTOSIS PATHWAY ENGAGEMENT
EHA Library, Hao Yao, 4159420
IMMUNOGLOBULIN GENE REARRANGEMENTS AND CLONAL EVOLUTION AS PROGNOSTIC FACTORS IN B-NHL: A NOVEL APPROACH FOR MOLECULAR RISK STRATIFICATION
EHA Library, Xiao Liu, 4159422
MOLECULAR AND CELLULAR RESPONSES TO EXTERNAL TRIGGERING IN PRIMARY SPLENIC SMALL B-CELL LYMPHOMAS: A TRANSCRIPTOMIC AND BIOENERGETIC PERSPECTIVE
EHA Library, Marina Gerousi, 4159423
ROLE OF NON-CODING RNAS AND DNA METHYLATION IN REGULATING INTRACELLULAR SIGNALING AND CYTOKINE PATHWAYS IN MYD88WT WALDENSTRÖM MACROGLOBULINEMIA: A MULTI-OMICS EPIGENETIC ANALYSIS
EHA Library, Karan Chohan, 4159424
TARGETING ARGININE METHYLTRANSFERASE PRMT5 AS A PROMISING THERAPEUTIC STRATEGY IN NKTCL
EHA Library, Siyu Qian, 4159425
MYD88 MUTATIONS ARE ASSOCIATED WITH DISEASE PROGRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Issa Ismail Issa, 4159426
CIRCULAR RNAS, PROMISING THERAPEUTIC TARGETS IN ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
EHA Library, Loélia Babin, 4159427
THE RATIO OF BRAIN TO LIVER GLUCOSE ACTIVITY AND PROGNOSIS WITH CAR-T IN NON-HODGKIN LYMPHOMA
EHA Library, Sarah Dingli, 4159428
DEFERASIROX AS A NOVEL THERAPY TO OVERCOME MCL1-DRIVEN THERAPY ESCAPE IN MANTLE CELL LYMPHOMA
EHA Library, Saar Shapira, 4159429
DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): PROGNOSTIC IMPACT OF CD30 EXPRESSION AND ITS ASSOCIATION WITH THE TUMOR MICROENVIRONMENT
EHA Library, Ken Naganuma, 4159430
ROR1 SMALL MOLECULE INHIBITOR OVERCOMES IBRUTINIB AND VENETOCLAX RESISTANCE IN MANTLE CELL LYMPHOMA (MCL)
EHA Library, Wen Zhong, 4159431
IMMUNOGENETIC LANDSCAPE OF WALDENSTRÖM MACROGLOBULINEMIA: CORRELATION WITH CLINICO-BIOLOGICAL FEATURES, PROGNOSIS AND COMPARISON WITH PHYSIOLOGICAL MEMORY-B CELLS AND PLASMA CELLS
EHA Library, Clotilde Bravetti, 4159432
GENOMIC PROFILING IDENTIFIES UNIQUE MOLECULAR SUBGROUPS IN SPLENIC SMALL B-CELL LYMPHOMAS
EHA Library, Antonia-Zoe Kouroutzidou, 4159433
INVESTIGATING THE PATHOGENIC MECHANISMS OF ANGIOPATHY IN SYSTEMIC CHRONIC ACTIVE EPSTEIN-BARR VIRUS DISEASE USING ENDOTHELIAL CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS
EHA Library, Miwako Nishio, 4159434
LCP2 MEDIATES SUV39H1-DRIVEN CELLULAR SENESCENCE-RELATED CHEMORESISTANCE IN NATURAL KILLER/T CELL LYMPHOMA
EHA Library, Yue Zhang, 4159435
TMSB4X 5'UTR ALTERATIONS ARE POSSIBLE DRIVER EVENTS HARBOURING PHASED VARIANTS WITH A POTENTIAL FOR DISEASE MONITORING ACROSS DLBCL GENETIC SUBGROUPS.
EHA Library, Luca Varga, 4159436
CHEMOCHINE RECECPTOR PROFILES AS PREDICTOR OF SURVIVAL AND EARLY PROGRESSION IN FOLLICULAR LYMPHOMA
EHA Library, Antonella Zupo, 4159437
DISTINCT IMMUNOGENETIC PROFILES IN SPLENIC SMALL B-CELL LYMPHOMAS: A REFLECTION OF DISTINCT ONTOGENY?
EHA Library, Anastasia Iatrou, 4159438
C-MYC ONCOPROTEIN IS STABILIZED BY FGFR ACTIVATION IN C-MYC-DRIVEN B-CELL NON-HODGKIN LYMPHOMA
EHA Library, Giulia Garattini, 4159439
VASCULAR ENDOTHELIAL CELLS IN SECONDARY LYMPHOID ORGANS PRIME ALLOREACTIVE CD4+ T CELLS IN ACUTE GRAFT-VERSUS-HOST DISEASE
EHA Library, Haroon Shaikh, 4159440
HYPOXIA-DRIVEN T CELL-MACROPHAGE-STROMAL CROSSTALK SUSTAINS FIBROSIS IN CUTANEOUS CHRONIC GVHD VIA THE HIF1α/PI3KΔ/IL-13 AXIS
EHA Library, Yuxi Xu, 4159441
RUXOLITINIB-INDUCED STAT3/BCL3 INHIBITION ACTIVATES NF-κB SIGNALING PATHWAY AND PROMOTES THE ACCUMULATION AND IMMUNOSUPPRESSIVE ACTIVITY OF G-MDSCS DURING ACUTE GRAFT-VERSUS-HOST DISEASE
EHA Library, Dai-Hong Liu, 4159442
MULTI-OMIC SEQUENCING IDENTIFIES NOVEL FACS MARKERS FOR PLATELET-BIASED HSC PURIFICATION
EHA Library, Bowen Zhang, 4159443
KERATIN 8 ENHANCES THE EFFICACY OF MESENCHYMAL STEM CELL IN THE TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE
EHA Library, Qing Xu, 4159444
OVERCOMING TOXIC CONDITIONING IN HEMATOPOIETIC STEM CELL THERAPY LEVERAGING MOBILIZATION-RESISTANT CXCR4 VARIANTS
EHA Library, Gabriele Pedrazzani, 4159445
IMMUNE MODULATION IN LEUKEMIA PATIENTS AFTER HEMATOPOETIC STEM CELL TRANSPLANTATION WITH ACUTE OR CHRONIC GRAFT VS HOST DISEASE (A/CGVHD): 12-WEEK EXTRACORPOREAL PHOTOPHERESIS (ECP) REDUCES INFLAMMATORY AND ENHANCES INHIBITORY IMMUNE REACTIVE CELLS
EHA Library, Anying Huang, 4159446
DYNAMICS OF OVERALL AND ORGAN-SPECIFIC RESPONSES TO AXATILIMAB IN CHRONIC GRAFT-VERSUS-HOST DISEASE: ANALYSIS FROM THE AGAVE-201 STUDY
EHA Library, Mi Kwon, 4159447
EMAPALUMAB IN PATIENTS WITH PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: EFFICACY AND SAFETY OUTCOMES FROM A MULTINATIONAL, OPEN-LABEL, SINGLE-ARM STUDY
EHA Library, Franco Locatelli, 4159448
HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ERCC6L2 DISEASE
EHA Library, Marja Hakkarainen, 4159449
IMPROVED OVERALL SURVIVAL FOLLOWING INTRODUCTION OF REDUCED TOXICITY CONDITIONING IN ALLO-HCT FOR MDS: A 25-YEAR RETROSPECTIVE SINGLE-CENTER ANALYSIS
EHA Library, Johanne Schovsbo, 4159450
ENTEROCOCCUS DEVASTATES THE GUT MICROBIOTA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION VIA THE PHOSPHOTRANSFERASE SYSTEM
EHA Library, Akihisa Hino, 4159451
SAFETY IN PARTICIPANTS WITH HEMATOLOGIC MALIGNANCIES WHO RECEIVED ALLOGENEIC STEM CELL TRANSPLANT FOLLOWING PEMBROLIZUMAB THERAPY: FINAL ANALYSIS FROM 10 PEMBROLIZUMAB CLINICAL STUDIES
EHA Library, John Kuruvilla, 4159452
CORRELATIONS OF CLINICIAN-REPORTED RESPONSES WITH OTHER RESPONSE MEASURES IN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE: AN ANALYSIS FROM THE AGAVE-201 TRIAL
EHA Library, Valkal Bhatt, 4159453
UNMET NEEDS IN CGVHD MANAGEMENT: REAL-WORLD ANALYSIS OF BASELINE AND DISEASE CHARACTERISTICS IN EUROPEAN AND SPANISH PATIENTS PREVIOUSLY TREATED WITH 2 TO 5 LINES OF THERAPY
EHA Library, Carlos Solano, 4159454
EFFECT OF ANTI-THYMOCYTE GLOBULIN AND POST-TRANSPLANT CYCLOPHOSPHAMIDE ON GVHD OUTCOMES IN FEMALE-TO-MALE MATCHED UNRELATED DONOR ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE LEUKEMIA
EHA Library, Nihar Desai, 4159455
OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH NUP98-REARRANGED ACUTE MYELOID LEUKAEMIA:A SINGLE-CENTER LARGE-SAMPLE COHORT STUDY
EHA Library, hai he, 4159456
HUMAN AMNIOTIC EPITHELIAL CELLS (HAECS) IS SAFE AND EFFECTIVE FOR STEROID REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: RESULTS OF A PHASE I STUDY
EHA Library, Xiao-Dong Mo, 4159457
PHARMACOGENETIC PROFILING OF ALLOGENEIC STEM CELL TRANSPLANTATION PATIENTS
EHA Library, Lea Timmann, 4159458
COMPARISON OF HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM OFFSPRING OR MATCHED UNRELATED DONOR IN PATIENTS AGED 40-50 WITH RELAPSED OR REFRACTORY SEVERE APLASTIC ANEMIA: A RETROSPECTIVE ANALYSIS FROM THE CBMTR OVER THE LAST DECADE
EHA Library, Xin Zhao, 4159459
COMPARATIVE OUTCOMES OF HAPLOIDENTICAL TRANSPLANTATION IN SAML VS. DE NOVO AML: A PROPENSITY-MATCHED COHORT STUDY
EHA Library, Nan Yang, 4159460
VALIDATION OF REDUCED BUSULFAN-BASED MODIFIED POST-TRANSPLANT CYCLOPHOSPHAMIDE REGIMEN IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA: A PROSPECTIVE COMPARATIVE STUDY
EHA Library, Donghua Zhang, 4159461
OUTCOME AFTER AUTOLOGOUS CORD BLOOD TRANSPLANTATION FOR PEDIATRIC ACQUIRED APLASTIC ANEMIA:A RETROSPECTIVE ANALYSIS OF MULTICENTER STUDY IN CHINA
EHA Library, Jiao Chen, 4159462
COMBINATION OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH UNRELATED UMBILICAL CORD BLOOD IN PATIENTS WITH APLASTIC ANEMIA: A RETROSPECTIVE STUDY OF 30 CASES
EHA Library, Yu Zhang, 4159463
CLADRIBINE AND MEDIUM-DOSE CYTARABINE INTENSIFIED BUSULFAN PLUS CYCLOPHOSPHAMIDE CONDITIONING REGIMEN FOR ADULTS HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Yajing Xu, 4159464
HIGH DAY 90 NK CELL COUNTS IN EVENT-FREE PATIENTS PREDICT IMPROVED SURVIVAL AFTER IN VIVO T-CELL DEPLETED ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Andrej Pešić, 4159465
CLINICAL OUTCOMES OF PATIENTS WITH CORONARY ARTERY DISEASE UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Zhixue Li, 4159466
PROGNOSTIC VALUE OF PET/CT IN ADULT T-CELL LYMPHOBLASTIC LYMPHOMA PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Fangfang Yu, 4159467
THIOTEPA-BUSULFAN-FLUDARABINE CONDITIONING REGIMEN WITH ATG/PTCY-BASED GVHD PROPHYLAXIS AS PROMISING APPROACH FOR HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE-CENTER, OPEN-LABEL, PROSPECTIVE STUDY
EHA Library, Xianbo Huang, 4159468
CHARACTERISTICS AND PROGNOSIS OF CENTRAL NERVOUS SYSTEM RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH LEUKEMIA
EHA Library, Yu Wang, 4159469
THE IMPACT OF BLAST PERCENTAGE ON POST-TRANSPLANT OUTCOMES OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A RETROSPECTIVE ANALYSIS WITHIN THE IPSS-M FRAMEWORK
EHA Library, Zhong-Shi Lyu, 4159470
THE REAL-WORLD STUDY OF TRANSPLANTATION-ASSOCIATED THROMBOTIC MICROANGIOPATHY IN ASCIAN ADULT ALLO-HSCT PATIENTS
EHA Library, Yibo Wu, 4159471
A SINGLE-CENTER RETROSPECTIVE STUDY ON MYELOABLATIVE CONDITIONING REGIMEN COMBINED WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SECONDARY ACUTE MYELOID LEUKEMIA.
EHA Library, Nan Yang, 4159472
THE IMPACT OF EASIX SCORE ON MORTALITY AFTER IN VIVO T-CELL DEPLETED ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Andrej Pešić, 4159473
ORGAN-SPECIFIC EXTRANODAL INVOLVEMENT IN STAGE IV DIFFUSE LARGE B-CELL LYMPHOMA PREDICTS THE EFFICACY OF FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION
EHA Library, Youngwoo Jeon, 4159474
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN TREATMENT OF SHWACHMAN-DIAMOND SYNDROME: A REPORT OF 19 PEDIATRIC CASES FROM A SINGLE CENTER
EHA Library, Jiao Chen, 4159476
A NOVEL REDUCED TOXICITY CONDITIONING REGIMEN FOR OLDER MYELODYSPLASTIC NEOPLASMS PATIENTS UNDERGOING HAPLOIDENTICAL STEM CELL TRANSPLANTATION: A PROSPECTIVE COHORT STUDY
EHA Library, Wenjing Yu, 4159477
CRYOPRESERVATION OF OVARIAN TISSUE IN 46 PEDIATRIC GIRLS BEFORE UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Jiao Chen, 4159478
PRE-TRANSPLANT MNGS-GUIDED LETERMOVIR PROPHYLAXIS REDUCES POST-HSCT CMV REACTIVATION: A PROSPECTIVE RISK STRATIFICATION STUDY
EHA Library, Xiaowen Tang, 4159479
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT FOR CHILDREN
EHA Library, Juan Xiao, 4159480
LENALIDOMIDE MAINTENANCE AFTER DELAYED OR SALVAGE AUTOLOGOUS STEM CELL TRANSPLANTATION
EHA Library, Asad A. Haider, 4159481
PATIENTS WITH MDS/MPN,NOS SHOW A LESS AGGRESSIVE DISEASE COURSE COMPARED TO PATIENTS WITH CMML IN THE CONTEXT OF ALLOGENEIC HCT - AN ANALYSIS ACROSS 12 GERMAN CENTERS
EHA Library, Anna Hecht, 4159482
PRETRANSPLANT THROMBOTIC EVENTS AND THEIR IMPACT ON THE OUTCOMES OF ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Haixia Fu, 4159483
EFFICACY AND SAFETY OF BELUMOSUDIL MONOTHERAPY AND COMBINATION WITH RUXOLITINIB IN REFRACTORY CHRONIC GRAFT-VERSUS-HOST-DISEASE: A SINGLE CENTRE, REAL-WORLD EXPERIENCE
EHA Library, Vinay Anand Guntiboina, 4159484
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN GERMLINE DDX41 MUTATED PATIENTS WITH MYELOID MALIGNANCIES
EHA Library, Michael Loschi, 4159485
UNMET NEEDS IN CHRONIC GRAFT-VERSUS-HOST DISEASE MANAGEMENT: GREAT BRITAIN SUBSET ANALYSIS OF EUROPEAN PATIENTS TREATED ACROSS 2 TO 5 LINES OF THERAPY
EHA Library, Sandra Easdale, 4159486
THE IMPACT OF FEMALE-TO-MALE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ON SURVIVAL OUTCOMES VARIES BY RECIPIENT AGE.
EHA Library, Kosuke Takano, 4159487
A NOVEL REGIMEN OF DECITABINE COMBINED WITH REDUCED-INTENSITY CONDITIONING FOR OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA: A MULTICENTER, SINGLE-ARM, PHASE 2 TRIAL
EHA Library, Qifa Liu, 4159488
IMPACT OF PRE-TRANSPLANT INVASIVE FUNGAL DISEASE MANAGEMENT STRATEGIES ON POST-TRANSPLANT OUTCOMES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Xiaohui Zhang, 4159489
PULMONARY ARTERIAL HYPERTENSION IN ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION: EQUIVALENT SURVIVAL DEFICITS FOR PRETRANSPLANT AND POSTTRANSPLANT ONSET
EHA Library, Kexin Shen, 4159490
ALLOGENEIC STEM CELL TRANSPLANTATION OUTCOMES AFTER CPX-351 VS OTHER INDUCTION REGIMENS IN NEWLY DIAGNOSED SECONDARY ACUTE MYELOID LEUKEMIA
EHA Library, Gabriele Facchin, 4159491
COMPARATIVE OUTCOMES OF HCT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE IN OLDER ADULTS: THE IMPACT OF DONOR TYPE
EHA Library, Yosra Aljawai, 4159492
OPTIMIZED CONDITIONING REGIMEN ENHANCES TCRαß+ CELL DEPLETED HEMATOPOIETIC STEM CELL TRANSPLANTATION ENGRAFTMENT IN PATIENTS WITH THALASSEMIA MAJOR
EHA Library, Jianyun Liao, 4159493
IMPACT OF DARATUMUMAB INDUCTION ON STEM CELL MOBILIZATION IN PATIENTS WITH MULTIPLE MYELOMA
EHA Library, Melinda Tan, 4159494
EVALUATION OF CYCLOPHOSPHAMIDE FOR STEROID-REFRACTORY HEPATIC ACUTE GRAFT-VS-HOST DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Erlie Jiang, 4159495
A RETROSPECTIVE STUDY ON THE USE OF MESENCHYMAL STEM CELLS TO PREVENT GVHD AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AMONG PATIENTS WITH SEVERE THALASSEMIA
EHA Library, Shiqing Huang, 4159496
MYOSTEATOSIS BUT NOT SARCOPENIA IS OF PROGNOSTIC RELEVANCE IN THORACIC CT-SCANS PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Jule Ussmann, 4159497
DEVELOPMENT AND VALIDATION OF A CYTOKINE-BASED PREDICTIVE MODEL FOR ACUTE GVHD AND COMPOSITE OUTCOMES IN ATG-BASED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Yiyin Chen, 4159498
THE EFFICACY AND SAFETY OF BELUMOSUDIL IN TREATING PEDIATRIC CHRONIC GRAFT-VERSUS-HOST DISEASE, A REAL-WORLD STUDY
EHA Library, Min Zhou, 4159499
INCREASED CYCLOSPORINE LEVELS ARE ASSOCIATED WITH DECREASED TRANSPLANT-RELATED MORTALITY FOLLOWING ALLOGENEIC TRANSPLANT FOR MYELOFIBROSIS
EHA Library, John Marra, 4159500
OUTCOMES OF BLINATUMOMAB ADDED TO CONDITIONING REGIMEN OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENT WITH LOW MINIMAL RESIDUAL DISEASE
EHA Library, Bancheng Ye, 4159501
EVOLUTION OF TREATMENT PARADIGMS AND SURVIVAL OUTCOMES IN HODGKIN'S LYMPHOMA: A 20-YEARS' RETROSPECTIVE ANALYSIS OF 804 PATIENTS FROM A NATIONAL MEDICAL CENTER IN CHINA
EHA Library, Wenyan Yu, 4160282
EVALUATION OF GONADAL FUNCTION IN FEMALE PATIENTS WITH HODGKIN LYMPHOMA (HL) AND PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBCL) UNDERGOING CHEMOTHERAPY
EHA Library, Angeliki Georgopoulou, 4160283
EFFICACY AND SAFETY OF FIRST-LINE IBRUTINIB PLUS VENETOCLAX IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) WHO WERE OLDER OR HAD TP53 MUTATIONS IN THE SYMPATICO STUDY
EHA Library, Gottfried von Keudell, 4160284
TQB2825, A NOVEL 2:1 STRUCTURED CD20XCD3 BISPECIFIC ANTIBODY,IN THE RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
EHA Library, Keshu Zhou, 4160285
CAN MANTLE CELL LYMPHOMA BE CURED? INSIGHTS FROM 25 YEARS OF FOLLOW-UP IN THE NORDIC MCL2 AND MCL3 TRIALS
EHA Library, Mats Jerkeman, 4160286
EPCORITAMAB MONOTHERAPY DEMONSTRATES DEEP AND DURABLE RESPONSES AT 3-YEAR FOLLOW-UP IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
EHA Library, Umberto Vitolo, 4160287
MINIMAL RESIDUAL DISEASE WITH BENDAMUSTINE-RITUXIMAB WITH OR WITHOUT ACALABRUTINIB IN PATIENTS WITH PREVIOUSLY UNTREATED MANTLE CELL LYMPHOMA: RESULTS FROM THE PHASE 3 ECHO TRIAL
EHA Library, Michael L. Wang, 4160288
MOSUNETUZUMAB DEMONSTRATES DURABLE CLINICAL BENEFIT IN PATIENTS (PTS) WITH COMPLETE RESPONSE (CR) AND HIGH-RISK RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)
EHA Library, Chan Cheah, 4160289
IMPACT OF RITUXIMAB MAINTENANCE ON SURVIVAL AMONG PATIENTS WITH MANTLE CELL LYMPHOMA; A POPULATION-BASED COHORT STUDY
EHA Library, Floriske Stedema, 4160290
EPCORITAMAB PLUS LENALIDOMIDE AND RITUXIMAB ACHIEVES HIGH RESPONSE RATES AND SURVIVAL BENEFITS COMPARED WITH USUAL CARE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: A COMPARATIVE ANALYSIS
EHA Library, Lorenzo Falchi, 4160291
A PROSPECTIVE MULTICENTER PHASE 2 STUDY OF THE CHEMOTHERAPY-FREE COMBINATION OF THE INTRAVENOUS PHOSPHATIDYLINOSITOL-3-KINASE (PI3K) INHIBITOR COPANLISIB IN COMBINATION WITH OBINUTUZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (FL) AND A HIGH TUMOR BURDEN (ALTERNATIVE-C)
EHA Library, Christian Schmidt, 4160292
UPDATED SAFETY AND EFFICACY RESULTS OF A PHASE 1 STUDY OF THE NOVEL BCL2 INHIBITOR SONROTOCLAX (BGB-11417) FOR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA
EHA Library, Chan Y. Cheah, 4160293

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings